Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
RESEARCH TOOLSreports
Total Valuation
West Pharmaceutical Services has a market cap or net worth of $15.37B. The enterprise value is $23.83B.
Market Cap$15.37B
Enterprise Value$23.83B
Share Statistics
West Pharmaceutical Services has 72.29M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding72.29M
Owned by Insiders0.55%
Owned by Instutions1.84%
Financial Efficiency
West Pharmaceutical Services’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 14.96%.
Return on Equity (ROE)18.37%
Return on Assets (ROA)13.52%
Return on Invested Capital (ROIC)14.96%
Return on Capital Employed (ROCE)18.43%
Revenue Per Employee$272,933.962
Profits Per Employee$46,481.132
Employee Count10,600
Asset Turnover0.79
Inventory Turnover5.03
Valuation Ratios
The current PE Ratio of West Pharmaceutical Services is 48.53. West Pharmaceutical Services’s PEG ratio is -3.13.
PE Ratio48.53
PS Ratio8.26
PB Ratio8.91
Price to Fair Value8.91
Price to FCF86.51
Price to Operating Cash Flow36.60
PEG Ratio-3.13
Income Statement
In the last 12 months, West Pharmaceutical Services had revenue of $2.89B and earned $492.70M in profits. Earnings per share was $6.74.
Revenue$2.89B
Gross Profit$999.80M
Operating Income$574.50M
Pretax Income$585.50M
Net Income$492.70M
EBITDA739.80M
Earnings Per Share (EPS)6.74
Cash Flow
In the last 12 months, operating cash flow was $653.40M and capital expenditures -$377.00M, giving a free cash flow of $276.40M billion.
Operating Cash Flow$653.40M
Free Cash Flow$276.40M
Free Cash Flow per Share$3.82
Dividends & Yields
West Pharmaceutical Services pays an annual dividend of $0.21, resulting in a dividend yield of 0.39%
Dividend Per Share$0.21
Dividend Yield0.39%
Payout Ratio12.12%
Free Cash Flow Yield1.16%
Earnings Yield2.06%
Stock Price Statistics
Beta0.71
52-Week Price Change-44.44%
50-Day Moving Average232.26
200-Day Moving Average293.66
Relative Strength Index (RSI)41.10
Average Volume (3m)948.71K
Important Dates
West Pharmaceutical Services upcoming earnings date is Apr 24, 2025, Before Open.
Last Earnings DateFeb 13, 2025
Next Earnings DateApr 24, 2025
Ex-Dividend DateApr 30, 2025
Financial Position
West Pharmaceutical Services as a current ratio of 2.79, with Debt / Equity ratio of 0.11
Current Ratio2.79
Quick Ratio2.11
Debt to Market Cap<0.01
Net Debt to EBITDA-0.25
Interest Coverage Ratio189.97
Taxes
In the past 12 months, West Pharmaceutical Services has paid $107.50M in taxes.
Income Tax$107.50M
Effective Tax Rate18.36%
Enterprise Valuation
West Pharmaceutical Services EV to EBITDA ratio is 31.90, with an EV/FCF ratio of 85.85.
EV to Sales8.20
EV to EBITDA31.90
EV to Free Cash Flow85.85
EV to Operating Cash Flow36.32
Balance Sheet
West Pharmaceutical Services has $484.60M in cash and marketable securities with $302.30M in debt, giving a net cash position of -$182.30M billion.
Cash & Marketable Securities$484.60M
Total Debt$302.30M
Net Cash-$182.30M
Net Cash Per Share-$2.52
Tangible Book Value Per Share$35.14
Margins
Gross margin is 34.51%, with operating margin of 19.70%, and net profit margin of 17.03%.
Gross Margin34.51%
Operating Margin19.70%
Pretax Margin20.24%
Net Profit Margin17.03%
EBITDA Margin25.71%
EBIT Margin20.34%
Analyst Forecast
The average price target for West Pharmaceutical Services is $297.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$297.50
Price Target Upside42.26%
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast-1.93%
EPS Growth Forecast-15.47%